Table of Content





1. Executive Summary


2. Global Hepatitis A Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Hepatitis A Vaccine Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Hepatitis A Vaccine Market by Type
3.3.1: Inactivated vaccine
3.3.2: Live Attenuated Vaccine

3.4: Global Hepatitis A Vaccine Market by Application
3.4.1: Government Institution
3.4.2: Private Sector
3.4.3: Others






4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Hepatitis A Vaccine Market by Region
4.2: North American Hepatitis A Vaccine Market
4.2.2: North American Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others


4.3: European Hepatitis A Vaccine Market
4.3.1: European Hepatitis A Vaccine Market by Type: Inactivated vaccine and Live Attenuated Vaccine
4.3.2: European Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others


4.4: APAC Hepatitis A Vaccine Market
4.4.1: APAC Hepatitis A Vaccine Market by Type: Inactivated vaccine and Live Attenuated Vaccine
4.4.2: APAC Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others


4.5: ROW Hepatitis A Vaccine Market
4.5.1: ROW Hepatitis A Vaccine Market by Type: Inactivated vaccine and Live Attenuated Vaccine
4.5.2: ROW Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Hepatitis A Vaccine Market by Type
6.1.2: Growth Opportunities for the Global Hepatitis A Vaccine Market by Application

6.1.3: Growth Opportunities for the Global Hepatitis A Vaccine Market by Region

6.2: Emerging Trends in the Global Hepatitis A Vaccine Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Hepatitis A Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hepatitis A Vaccine Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: GlaxoSmithKline
7.2: Merck & Co
7.3: Sanofi
7.4: Sinovac
7.5: Zhejiang Pukang
7.6: Changchun Institute of Biological
7.7: KM Biologics
7.8: IMBCA
7.9: ChangSheng
7.10: Convac